Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07486271

Artificial Intelligence in Aortic Regurgitation

Artificial Intelligence in Aortic Regurgitation: A Multicenter Randomised Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
540 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research project aims to develop and validate a tool that uses artificial intelligence (AI) to automatically detect and quantify aortic regurgitation (AR). The clinical efficacy of this tool will be established by comparing it to manual diagnostic methods in a multicenter randomized controlled trial. By leveraging deep learning (DL) techniques, the AI system will automate aortic regurgitation (AR) detection, measurement, and diagnosis, addressing challenges like variability in echocardiographic interpretations and the need for specialized expertise. It will integrate multiple echocardiographic parameters to provide accurate, standardized, and efficient AR diagnoses, reducing human error and improving consistency. This tool will enhance diagnostic precision and accessibility, improving clinical outcomes and extending advanced diagnostic capabilities to a broader range of healthcare environments, including resource-limited settings.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAI-Assisted GroupParticipants in this group will undergo aortic regurgitation assessment using an advanced artificial intelligence tool.
OTHERManual measurement groupParticipants in this group will receive a traditional diagnostic assessment for aortic regurgitation, performed by trained sonographers following standard protocols.

Timeline

Start date
2025-12-01
Primary completion
2028-03-31
Completion
2028-03-31
First posted
2026-03-20
Last updated
2026-03-20

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT07486271. Inclusion in this directory is not an endorsement.